Indication
Bronchospasm prevention with COPD
Bronchospasm prevention with chronic obstructive pulmonary disease (COPD) refers to the prophylactic management of acute or recurrent airway constriction in adults with chronic obstructive pulmonary disease, including emphysema and chronic bronchitis. Read more about Bronchospasm prevention with COPD
80 drugs 43 manufacturers
Drugs that treat it
Common Bronchospasm prevention with COPD therapies.
IPRATROPIUM BROMIDE
IPRATROPIUM BROMIDE
TUDORZA PRESSAIR (aclidinium bromide)
IPRATROPIUM BROMIDE
BREO ELLIPTA (fluticasone furoate/vilanterol trifenatate)
ANORO ELLIPTA (umeclidinium bromide/vilanterol trifenatate)
BREO ELLIPTA (fluticasone furoate/vilanterol trifenatate)
TUDORZA PRESSAIR (aclidinium bromide)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonBronchospasm prevention with chronic obstructive pulmonary disease (COPD) refers to the prophylactic management of acute or recurrent airway constriction in adults with chronic obstructive pulmonary disease, including emphysema and chronic bronchitis.
This clinical state involves the sustained or sudden contraction of bronchial smooth muscle layered upon chronic, largely irreversible lower respiratory tract inflammation, parenchymal destruction, and structural remodeling.
Clinically, preventing this narrowing alleviates airflow limitation, reduces dynamic hyperinflation, and diminishes hallmark manifestations such as episodic dyspnea, wheezing, chest tightness, and the risk of acute exacerbations.
- nih.gov
Bronchospasm prevention with chronic obstructive pulmonary disease (COPD) refers to the prophylactic management of acute or recurrent airway constriction in adults with chronic obstructive pulmonary disease, including emphysema and chronic bronchitis This clinical state involves the sustained or sudden contraction of bronchial smooth muscle layered upon chronic, largely irreversible lower respiratory tract inflammation, parenchymal destruction, and structural remodeling
- lptmedical.com
Bronchospasm prevention with chronic obstructive pulmonary disease (COPD) refers to the prophylactic management of acute or recurrent airway constriction in adults with chronic obstructive pulmonary disease, including emphysema and chronic bronchitis This clinical state involves the sustained or sudden contraction of bronchial smooth muscle layered upon chronic, largely irreversible lower respiratory tract inflammation, parenchymal destruction, and structural remodeling Clinically, preventing th...
- mayoclinic.org
Bronchospasm prevention with chronic obstructive pulmonary disease (COPD) refers to the prophylactic management of acute or recurrent airway constriction in adults with chronic obstructive pulmonary disease, including emphysema and chronic bronchitis Clinically, preventing this narrowing alleviates airflow limitation, reduces dynamic hyperinflation, and diminishes hallmark manifestations such as episodic dyspnea, wheezing, chest tightness, and the risk of acute exacerbations
- nih.gov
Clinically, preventing this narrowing alleviates airflow limitation, reduces dynamic hyperinflation, and diminishes hallmark manifestations such as episodic dyspnea, wheezing, chest tightness, and the risk of acute exacerbations
Personalize your experience
Follow Bronchospasm prevention with COPD and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.